Filing Details
- Accession Number:
- 0001415889-21-001623
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-23 19:32:25
- Reporting Period:
- 2021-03-21
- Accepted Time:
- 2021-03-23 19:32:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1697362 | Burkes Michael Brophy | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-21 | 1,118 | $0.00 | 64,488 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-22 | 448 | $105.04 | 64,040 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-22 | 1,078 | $0.00 | 65,118 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-23 | 436 | $101.72 | 64,682 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Unit | Disposition | 2021-03-21 | 1,118 | $0.00 | 1,118 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2021-03-22 | 1,078 | $0.00 | 1,078 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct | ||
8,618 | No | 4 | M | Direct |
Footnotes
- Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 21, 2018.
- Each RSU represents a contingent right to receive one share of the common stock of the issuer.
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs pursuant to Rule 10b5-1.
- Represents the partial vesting and settlement of RSUs, starting March 22, 2020.
- The RSUs vest over four years. 25% of the RSUs vested on March 21, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter.
- The RSUs vest over four years. 25% of the RSUs vested on March 22, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.